一期感染髋关节置换治疗假体周围关节感染的十年结果
该回顾性队列纳入2006年1月至2007年12月因假体周围关节感染(PJI)行一期抗生素骨水泥假体全髋关节置换翻修的85例患者,随访10-11年。10年无感染生存率为94%,无手术生存率为75.9%,Harris髋关节评分从43改善至75(P < .001)。作者认为一期翻修是可靠的治疗选择,感染控制率高且长期结果良好。
要点
- 85例髋PJI患者行一期抗生素骨水泥假体翻修,10年无感染生存率94%,无手术生存率75.9%。
- Harris髋关节评分从术前43改善至末次随访75(P < .001)。
- 一期翻修后再翻修的主要指征为不稳(10/20例)。
核心结论
- 作者认为,一期髋关节翻修治疗PJI是可靠的治疗选择,感染控制率高且长期结果良好。
研究设计与样本
- 回顾性队列研究,纳入2006年1月至2007年12月因感染行一期翻修全髋关节置换术(THA)的患者,最少随访10年(范围10-11年),末次随访时85例髋PJI患者可获得数据。
- 排除来自另一国家的患者或无法参与的患者。
- 研究期间37例患者在10年内死亡。
主要发现
- 10年无感染生存率为94%,无手术生存率为75.9%。
- Harris髋关节评分从术前43(范围3-91)改善至末次随访75(范围10-91)(P < .001)。
- 一期翻修后再翻修的主要指征为不稳(10/20例患者)。
- 失败被报告为感染相关或无菌性失败。
关键数值与推荐
- 10年无感染生存率94%。
- 10年无手术生存率75.9%。
- Harris髋关节评分术前43(范围3-91)vs 末次随访75(范围10-91),P < .001。
- 再翻修主要指征不稳:10/20例患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although 2-stage revision is still considered the gold standard for surgical management of periprosthetic joint infection (PJI), 1-stage revision has been reported to be as effective. Long-term reports for 1-stage revision in hip PJIs are lacking. METHODS: We reviewed our 10-11 years of results of 85 patients who underwent 1-stage exchange of the hip with an antibiotic-loaded bone cemented prosthesis due to PJI to determine the following: (1) What is the infection-free survival? (2) What is the overall survival? and (3) What are the long-term clinical outcomes? All 1-stage revision total hip arthroplasties (THAs) for infection between January 2006 and December 2007, with a minimum 10-year follow-up (range 10-11), were included in this retrospective cohort. Patients from another country or patients who were unable to participate were excluded. Eighty-five patients with a hip PJI were available at the last follow-up. Thirty-seven patients died during the 10-year study. Harris Hip Scores were recorded before the surgery and at last follow-up. Failures are reported as infection-related or aseptic. RESULTS: The 10-year infection-free survival was 94% and the surgery-free survival was 75.9%. The Harris Hip Scores improved from 43 (range 3-91) to 75 (range 10-91) (P < .001). The main indication for re-revision after 1-stage exchange was instability (10/20 patients). CONCLUSION: One-stage exchange of the hip for PJI is a reliable treatment option with high rate of infection control and long-lasting favorable outcomes.
引用
- Zahar A, Klaber I, Gerken AM, et al. Ten-Year Results Following One-Stage Septic Hip Exchange in the Management of Periprosthetic Joint Infection. J Arthroplasty. 2019. PMID: 30857953. doi:10.1016/j.arth.2019.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。